References
- Liu L, Wu J, Geng J, et al. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open 2013;3:e003787. doi:10.1136/bmjopen-2013-003787.
- Liu T, Liu Y, Xie L, et al. Progress in the pathogenesis of pterygium. Curr Eye Res 2013;38:1191–1197.
- Janson BJ, Sikder S. Surgical management of pterygium. Ocul Surf 2014;12:112–119.
- Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 2007;18:308–313.
- Chui J, Coroneo MT, Tat LT, et al. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 2011;178:817–827.
- Huang YH, Chang NS, Tseng SH. Expression of WW domain-containing oxidoreductase WWOX in pterygium. Mol Vis 2015;21:711–717.
- Tsai YY, Chang KC, Lin CL, et al. p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea 2005;24:583–586.
- Tsukita S, Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000;149:13–16.
- Capaldo CT, Nusrat A. Claudin switching: physiological plasticity of the tight junction. Semin Cell Dev Biol 2015;42:22–29.
- Yoshida Y, Ban Y, Kinoshita S. Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium. Invest Ophthalmol Vis Sci 2009;50:2103–2108.
- Sheehan GM, Kallakury BV, Sheehan CE, et al. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007;38:564–569.
- Tierney P, de Gruijl FR, Ibbotson S, Moseley H. Predicted increased risk of squamous cell carcinoma induction associated with sunbed exposure habits. Br J Dermatol 2015;173:201–208.
- Goldberg LH, Mamelak AJ. Review ofactinic keratosis. Part I: etiology, epidemiology and clinical presentation. J Drugs Dermatol 2010;9:1125–1132.
- Arabzadeh A, Troy TC, Turksen K. Changes in the distribution pattern of claudin tight junction proteins during the progression of Mouse skin tumorigenesis. BMC Cancer 2007;7:196.
- Hintsala HR, Siponen M, Haapasaari KM, et al. Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin. Int J Clin Exp Pathol 2013;6:2855–2863.
- Gruber R, Börnchen C, Rose K, et al. Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis. Am J Pathol 2015;185:2777–2789.
- Malu KN. Allergic conjunctivitis in Jos-Nigeria. Niger Med J 2014;55:166–170.
- Lee JW, Lee SJ, Seo J, et al. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 2005;97:53–59.
- Sappayatosok K, Phattarataratip E. Overexpression of claudin-1 is associated with advanced clinical stage and invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma. Head Neck Pathol 2015;9:173–180.
- Venkov CD, Link AJ, Jennings JL, et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 2007;117:482–491.
- Kase S, Osaki M, Sato I, et al. Immunolocalisation of E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol 2007;91:1209–1212.